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The pharmacokinetics and pharmacodynamics of antie-
pileptic drugs (AEDs) differ in old age from those in
younger patients. Age-related changes in pharmacoki-
netics play a role as early as the drug absorption stage,
because gastric secretion, blood volume, blood flow, and
gastrointestinal motility are all lower in old age. The
serum concentration of the medications is heavily influ-
enced by protein binding, mainly of serum albumin,
whose concentration is markedly reduced in old age, so
that the free fraction of medication in the serum is
higher. This influences not only the desired medication
effects, but also the undesired ones, and is particularly
important in the case of highly protein-bound antiepi-
leptic drugs such as valproic acid, phenytoin, or carba-
mazepine. In elderly patients a reduction of hepatic and
renal function were observed. No guidelines, systematic
reviews, or meta-analyses on this subject are available.
There have been only three randomized, controlled,
double-blind therapeutic trials of evidence class I or II
regarding epilepsy in the elderly, as well as a number of
smaller studies of classes IIa and III. Thus, many clinical
decisions about antiepileptic treatment in old age are
based on extrapolations of experience and data obtained
from younger patients, combined with the general prin-
ciples of pharmacotherapy in old age. The treatment of
epilepsy seems to be successful in the elderly more
often than in young adults. A precondition for success-
ful treatment, however, is that the antiepileptic drug is
well tolerated and does not interact with other, concur-
rently taken, medications. The treatment of epilepsy in
an elderly patient generally requires searching for the
medication that is best tolerated and least metabolized.
Problems can arise because drug-drug interactions must
be considered in the elderly people that often take mul-
tiple medications. It is evident that the so-called
enzyme-inducing antiepileptic drugs (carbamazepine,
phenytoin, phenobarbital) generally cannot be
recommended for use in elderly patients because of
their multifarious interaction. Moreover these AEDs
may facilitate the development of osteoporosis and can-
not be recommended for use in elderly woman patients.
Recently, clinical studies have shown a better tolerability
of never antiepileptic drugs. In conclusion numerous
factors must be considered in treating elderly patients
for seizures, but maximizing the ability of patients to
tolerate drug therapy is often the basis for AED
selection.
Published: 19 May 2010
doi:10.1186/1471-2318-10-S1-L47
Cite this article as: Siniscalchi: Treatment of epilepsy in the elderly
people. BMC Geriatrics 2010 10(Suppl 1):L47.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Department of Neuroscience, Neurology Division, “Annunziata” Hospital,
Cosenza, Italy
Siniscalchi BMC Geriatrics 2010, 10(Suppl 1):L47
http://www.biomedcentral.com/1471-2318/10/S1/L47
© 2010 Siniscalchi; licensee BioMed Central Ltd.
